Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs
Bristol-Myers Squibb (NYSE: BMY) Delayed: 63.83 -0.82 (1.27%)
Previous Close $64.65    52 Week High $77.12 
Open $64.13    52 Week Low $49.03 
Day High $64.33    P/E 41.45 
Day Low $63.35    EPS $1.54 
Volume 7,529,798       

(NASDAQ: IMTX) Delayed: 9.44 -0.15 (1.56%)
Previous Close $9.59    52 Week High $ 
Open $9.68    52 Week Low $ 
Day High $9.68    P/E N/A 
Day Low $9.39    EPS $ 
Volume 362,693